Due to weak binding to its receptor, FGF-23 usually requires a co-factor, Klotho, except in the state of advanced CKD and excessive levels of FGF-23, where it exerts its biological action even without Klotho [56]. The gene discussed is KL; the disease is chronic kidney disease.